NCT07394010

Brief Summary

Heart failure affects 1-2% of the adult population. Up to half of these patients have apparently normal heart pumping function, known as heart failure with preserved ejection fraction (HFpEF). Because HFpEF typically occurs in elderly patients with multiple comorbidities, many different mechanisms could drive symptoms and life expectancy, and it has been difficult to find effective treatments that work for all. Symptoms of HFpEF occur during exertion. The current scoring system for the diagnosis of HFpEF is not able to identify the majority of people and the majority of people remain in the zone of diagnostic uncertainty; there is no definite follow-up strategy, thus people do not receive appropriate treatment. Also, the medications, prehabilitation, and rehabilitation services are not personalised. To cater to these gaps in clinical practice, this study was set up to use Cardiopulmonary exercise testing (CPET) to understand the complexity of this disease. The investigators plan to recruit patients with clinical suspicion of HFpEF, referred to the Cardiology Department at Ulster Hospital, Belfast, UK. After screening the medical records of patients based on the inclusion and exclusion criteria, the investigators recruited 40 patients to undergo a cardiopulmonary exercise test. CPET parameters related to the heart, lungs and muscles were recorded in real time, as the patient exercised on the bike to maximal effort. The CPET data were then analysed to answer the above-mentioned clinical gaps. To disseminate the findings, the investigators plan to present the results at scientific, clinical, and patient group meetings and publish the findings in medical journals, to reach a wide array of healthcare professionals and policymakers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 21, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
Last Updated

February 6, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

January 21, 2026

Last Update Submit

January 30, 2026

Conditions

Keywords

Cardiopulmonary Exercise TestingCPETHFpEFHeart Failure with Preserved Ejection Fraction

Outcome Measures

Primary Outcomes (1)

  • Maximum Oxygen Consumption at peak exercise (VO2peak)

    Measure of exercise capacity.

    CPET testing day. VO2peak is recorded as the oxygen consumption value measured by the gas sensor at the peak of exercise, i.e., seconds before maximal exhaustion.

Secondary Outcomes (3)

  • First Ventilatory Threshold

    CPET testing day. Measured during the initial 3 minutes of the incremental test phase.

  • Heart Rate

    Baseline, every 2 minutes interval, and at peak exercise near maximal exhaustion.

  • Blood Pressure

    Every 3-minute interval during the exercise test.

Study Arms (1)

Patents referred to Cardiology Department with a clinical suspicion of HFpEF

Males and Females Age range: 18 to 80 Ejection fraction \>50% on the latest Echocardiography No Hospital admission in the past 6 months No pregnant No absolute contraindication for conducting an exercise test.

Other: Cardiopulmonary Exercise Test

Interventions

It is the gold standard for assessing cardiorespiratory fitness. It assesses the combined functional capacity of the multiple systems of the body.

Also known as: CPET
Patents referred to Cardiology Department with a clinical suspicion of HFpEF

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients registered with the South Eastern Health and Social Trust (NHS), Northern Ireland, UK.

You may qualify if:

  • Male and female
  • Age range between 18 - 80 years
  • Clinical suspicion of Heart failure with preserved ejection fraction
  • Ejection Fraction of ≥50% on the most recent Echocardiogram
  • Able to understand the performance of an exercise test and the ability to provide consent
  • Ability to undertake leg exercise without any impediment

You may not qualify if:

  • Hospital admission in the past 6 months
  • Unable to understand the performance of an exercise test
  • Unable to provide informed consent
  • Female subjects who are knowingly pregnant or believe they may be pregnant
  • Having an impediment preventing them from performing cycle ergometry
  • Contra-indication of CPET: acute myocardial infarction, unstable angina, uncontrolled arrhythmias, moderate or severe valvular disease, High-degree atrioventricular block, acute infection, acute endocarditis, myocarditis, uncontrolled asthma, and history of syncope.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ulster University and Ulster Hospital

Belfast, Middlesex, BT16 1RH, United Kingdom

Location

Related Links

MeSH Terms

Interventions

Exercise TestClostridium perfringens epsilon-toxin

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Chris Bleakley, PhD

    Ulster University, Belfast, UK

    STUDY DIRECTOR
  • George Kernohan, PhD

    Ulster University, Belfast, UK

    STUDY DIRECTOR
  • Peter McKavanagh, MD, PhD

    Ulster Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2026

First Posted

February 6, 2026

Study Start

June 1, 2023

Primary Completion

June 10, 2025

Study Completion

June 10, 2025

Last Updated

February 6, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Study Protocol

Shared Documents
STUDY PROTOCOL
Time Frame
From March 2026 onwards
Access Criteria
Freely available online for anyone to access
More information

Locations